/

Empresas

Ar

No verificado

Arima Genomics, Inc.

Sobre qué escribimos

BiotecnologíaCienciaMedicina - VariosOncologíaSalud

12 Comunicados de prensa

Ver todos los comunicados de prensa

16/06/2026

Eventos

Industria

Biotecnología

Salud

Oncología

Arima Genomics Named to Fast Company’s 2026 World Changing Ideas List for Aventa Lymphoma Test

Fuente

Arima Genomics, Inc.

Editor

1.00

0

11/06/2026

Eventos

Oncología

Salud

Biotecnología

Ciencia

Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection

Fuente

Arima Genomics, Inc.

Editor

1.00

0

15/04/2026

Eventos

Oncología

Salud

Biotecnología

Ciencia

Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors

Fuente

Arima Genomics, Inc.

Editor

1.00

0

26/02/2026

Industria

Ciencia

Biotecnología

Medicina - Varios

Salud

Farmacéutica

Sanidad

Oncología

Arima Genomics Announces Publication of New Study Supporting the Whole-Genome Rearrangement Detection Approach Behind Aventa Lymphoma

Fuente

Arima Genomics, Inc.

Editor

1.00

0

04/12/2025

Eventos

Ferias y Congresos

Ciencia

Medicina - Varios

Asociaciones/Profesionales

Biotecnología

Salud

Oncología

Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma

Fuente

Arima Genomics, Inc.

Editor

1.00

0

13/11/2025

Ciencia

Biotecnología

Oncología

Salud

Medicina - Varios

Sanidad

Eventos

Industria

Arima Genomics Announces Data Presentation at the Association for Molecular Pathology 2025

Fuente

Arima Genomics, Inc.

Editor

1.00

0

06/11/2025

Eventos

Industria

Oncología

Salud

Biotecnología

Medicina - Varios

Ciencia

Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year”

Fuente

Arima Genomics, Inc.

Editor

1.00

0

15/10/2025

Material médico sanitario

Salud

Biotecnología

Medicina - Varios

Oncología

Industria

Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases

Fuente

Arima Genomics, Inc.

Editor

1.00

0

03/09/2025

Biotecnología

Salud

Oncología

Material médico sanitario

Industria

Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas

Fuente

Arima Genomics, Inc.

Editor

1.00

0

17/06/2025

Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing

Fuente

Arima Genomics, Inc.

Editor

1.00

0

Seguidores

0

Compatibilidad

0